Віденська приватна клініка (Wiener Privatklinik)
| Австрія | Туреччина | Україна | |
| Хіміотерапія при раку молочної залози | від $15,000 | від $1,200 | від $1,200 |
| Резекція кістки | від $25,000 | від $8,000 | від $8,000 |
| Променева терапія при саркомі | від $18,000 | від $3,250 | від $3,200 |
| Променева терапія при раку прямої кишки | від $12,000 | від $7,000 | від $4,500 |
| Операція при саркомі | від $35,000 | від $10,000 | від $12,000 |
Ви не сплачуєте за послуги Bookimed. Ціни на лікування саркома юїнга відповідають прайс-листу клініки. Ви сплачуєте безпосередньо в клініці. Доступна оплата частинами.
Bookimed піклується про вашу безпеку. Ми співпрацюємо лише з медичними закладами, які дотримуються високих міжнародних стандартів у лікуванні саркома Юїнга та мають необхідні ліцензії для обслуговування пацієнтів з різних країн.
Bookimed надає безкоштовну експертну підтримку. Особистий лікар-координатор супроводжує вас до, під час та після лікування, вирішуючи будь-які питання. Ви ніколи не залишитеся наодинці на шляху лікування саркома Юїнга.
Austria follows the international iEuroEwing clinical trial framework for Ewing's sarcoma. This multimodel protocol features induction chemotherapy followed by local surgery or radiotherapy. Treatment concludes with consolidation chemotherapy. Austrian specialists prioritize limb-sparing techniques and precise radiation to maximize survival while preserving physical function.
Bookimed Expert Insight: Most Austrian oncology centers concentrate therapy in specialized multidisciplinary departments. For example, Wiener Privatklinik operates over 26 departments. This structure allows orthopedic surgeons and oncologists to collaborate daily. Such integration ensures that local therapy timing aligns perfectly with chemotherapy cycles for better outcomes.
Patient Consensus: Patients emphasize that chemotherapy is the primary treatment backbone rather than just an add-on. Many recommend requesting a second pathology review early. They also note that discussing fertility preservation is vital before starting intensive protocols.
Austria offers advanced limb-sparing surgery for bone tumors like Ewing's sarcoma. Specialized centers achieve a 90% limb-salvage rate for complex sarcomas. Surgeons prioritize tumor removal with clean margins. They use internal megaprostheses and 3D-printed implants to preserve function and appearance.
Bookimed Expert Insight: Wiener Privatklinik provides a unique advantage by giving patients access to university professors. These doctors also work at the Medical University of Vienna. This bridge lets private patients receive academic-level surgical expertise. They benefit from highly personalized care in a 130-bed boutique environment.
Patient Consensus: Patients emphasize that success depends on tumor shrinkage after chemotherapy. They note that while saving the limb is the priority, achieving clean margins is vital. Most recommend choosing high-volume centers where surgeons perform these complex reconstructions routinely.
Austria treats Ewing's sarcoma at specialized university centers and private oncology institutes in Vienna and Innsbruck. These facilities utilize multidisciplinary teams to provide integrated chemotherapy, limb-sparing surgery, and proton therapy. Recognized institutions including Wiener Privatklinik and major university hospitals achieve high success rates for complex pediatric and adult cases.
Bookimed Expert Insight: Wiener Privatklinik offers a unique advantage by bridging private care with academic expertise. While it operates as a private facility, its staff includes many professors from the Medical University of Vienna. This allows patients to receive university-level surgical and oncological protocols within a more personalized, 130-bed boutique environment. Patients seeking rapid access to high-ranking specialists often choose this route to avoid public system wait times for complex diagnostics like PET-CT or specialized biopsies.
Patient Consensus: Patients emphasize that a multidisciplinary center must coordinate the entire treatment sequence from the initial biopsy. Seeking a second pathology review for small round blue cell tumors is also a common recommendation to ensure diagnostic accuracy.
Patients in Austria receive Ewing's sarcoma treatment in specialized units based on age. Children and adolescents stay in pediatric oncology wards. Adults visit orthopedic oncology or medical oncology departments. These units offer age-appropriate care within larger institutional cancer networks to ensure safety.
Bookimed Expert Insight: Clinics like Wiener Privatklinik leverage a multidisciplinary network of over 400 physicians. Many are professors at the Medical University of Vienna. Data shows these academic connections allow adult patients to access pediatric-derived Ewing's protocols. This collaboration is vital because adult sarcoma units often apply the intensive regimens originally developed for children. Look for centers with an International Oncology Center designation for the most integrated care.
Patient Consensus: Patients note that age cutoffs can be flexible for young adults. They emphasize that finding a center with a dedicated sarcoma board is more important than the specific ward label.
Austria offers advanced proton and carbon-ion therapy at MedAustron in Wiener Neustadt. This facility is one of 6 centers globally delivering both types of particle therapy. These treatments provide extreme precision. They are especially effective for pediatric Ewing's sarcoma near critical structures.
Bookimed Expert Insight: While MedAustron provides the physical radiation, the treatment plan often originates at a university-affiliated clinic. Bookimed data shows Wiener Privatklinik physicians are frequently professors at the Medical University of Vienna. These doctors use specialized software to bridge the gap between surgical resection and advanced particle radiation. This academic connection ensures that even for rare conditions like Ewing's sarcoma, the radiotherapy is integrated into a comprehensive, multidisciplinary surgical plan.
Patient Consensus: Patients emphasize that the primary benefit of protons is reducing long-term side effects in young people. Many note that getting a referral from a major sarcoma-specific oncology team is the most effective way to access these niche technologies.